Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000021958 | SCV001392320 | pathogenic | Biotinidase deficiency | 2023-04-06 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 237 of the BTD protein (p.Ala237Thr). For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt BTD protein function. ClinVar contains an entry for this variant (Variation ID: 25036). This missense change has been observed in individual(s) with partial biotinidase deficiency (PMID: 26810761; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is present in population databases (rs397514381, gnomAD 0.004%). |
Baylor Genetics | RCV000021958 | SCV004211427 | likely pathogenic | Biotinidase deficiency | 2023-09-09 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000021958 | SCV002081562 | uncertain significance | Biotinidase deficiency | 2021-02-15 | no assertion criteria provided | clinical testing |